2022年6月博士毕业于四川大学华西基础医学与法医学院，中美联合培养博士。2022年10月加入四川大学华西基础医学与法医学院生物医学工程研究室。作为负责人主持国家自然科学基金青年项目1项，省部级科研项目3项，校/院级项目各1项，参研国家自然科学基金面上项目2项，四川省自然科学基金项目2项。以第一/共一作者在Biomaterials、Theranostcis、Bone Research、Genes Dis、 Regen Biomater等期刊发表论文10余篇，授权专利2项。

研究方向：

心脑血管疾病的力学发病机制及药物递送治疗

代表性论文（#为共同一作）

1.Fei Fang,et al., Xiaoheng Liu*.Macrophage-based pathogenesis and theranostics of vulnerable plaques.Theranostics, 2025,15(4):1570-1588.(IF:12.4)

2.Chunli Li^#,Fei Fang^#, et al.,Zhen Zhang*,Xiaoheng Liu*.Engineering extracellular vesicles derived from endothelial cells sheared by laminar flow for anti-atherosclerotic therapy through reprogramming macrophage.Biomaterials,2025,314:122832.(IF:12.8)

3.Fei Fang,et al., Xiaoheng Liu*& Chenchen Zhou*.The role and applications of extracellular vesicles in osteoporosis.Bone Research, 2024, 12: 4.(IF:14.3，ESI高被引)

4.Fei Fang, et al.,Jing Xie*,Xiaoheng Liu*.Injectable Alginate-Based Hydrogels Encapsulating Engineered Endothelial Extracellular Vesicles for the Treatment of Critical Limb Ischemia.Biomacromolecules, 2024, 25(10): 6656-6665.(IF:5.5)

5.Fei Fang, et al., Yang Shen*, Xiaoheng Liu*.Cathepsin K Contributed to Disturbed Flow-induced Atherosclerosis is Dependent on Integrin-actin Cytoskeleton-NF-κB Pathway.Genes & Diseases,2023, 10(2):583-595.(IF:6.9)

6.Fei Fang, et al., Xiaoheng Liu*, Song Li*.Tuning Macrophages for Atherosclerosis Treatment.Regenerative Biomaterials, 2023, 10:rabc103. (IF: 5.6)

7.Fei Fang, et al., Song Li*, Yang Shen* and Xiaoheng Liu*. Inflammatory Endothelium-targeted and Cathepsin Responsive Nanoparticles are Effective Against Atherosclerosis.Theranostics,2022,12(9):4200-4220.(IF:12.4，封面文章)

8.Wei Tang#,Fei Fang#, Ke Liu#, et al.,Yazhou Wang*.Aligned Biofunctional Electrospun PLGA-LysoGM1 Scaffold for Traumatic Brain Injury Repair.ACS Biomaterials Science & Engineering, 2020, 6(4). (IF: 5.4)

9.Fei Fang, etal., Yazhou Wang*.Non-invasive Approaches for Drug Delivery to the Brain Based on the Receptor Mediated Transport.Materials Science and Engineering: C,2017, 76(1):1316-1327 (IF:8.1)

10.Tiantian Li,Fei Fang,et al.,Guixue Wang*, Weihong He*, Xiaoheng Liu*.EGCG alleviates vascular calcification via the MAPK/JunB signaling pathway.Genes & Diseases, 2025, 12(1):101237.(IF:6.9)

主持项目

1.国家自然科学基金青年项目（32301089），30万，2024.1-2026.12，项目负责人。

2.四川自然科学基金青年项目（2024NSFSC1703），10万，2024.1-2025.12，项目负责人。

3.四川省博士后科研项目特别资助，5万，项目负责人。

4.国家博士后基金面上项目（2023M742454），8万，项目负责人。

5.四川大学专职博士后研发基金（2023SCU12035），15万，2023.1-2024.12，项目负责人。

6.华西基础医学与法医学院专职博士后启动基金，15万，2023.1-2024.12，项目负责人。